Todd Watanabe insider trades: Arcutis Biotherapeutics (ARQT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Todd reports to the SEC
Open-market buys and sales
59 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | ARQT | ↓ Sell | 4,377 | $31.86 | $139K | Direct | Nov 4, 2026 (2d) |
| Aug 3, 2026 | ARQT | ↓ Sell | 4,375 | $26.12 | $114K | Direct | Aug 5, 2026 (2d) |
| May 4, 2026 | ARQT | ↓ Sell | 3,172 | $23.61 | $75K | Direct | May 6, 2026 (2d) |
| Feb 2, 2026 | ARQT | ↓ Sell | 19,833 | $25.50 | $506K | Direct | Feb 4, 2026 (2d) |
| Nov 24, 2025 | ARQT | ↓ Sell | 50,000 | $30.35 | $1.5M | Direct | Nov 24, 2025 (0d) |
| Nov 3, 2025 | ARQT | ↓ Sell | 11,547 | $24.72 | $285K | Direct | Nov 5, 2025 (2d) |
| Oct 28, 2025 | ARQT | ↓ Sell | 40,000 | $25.03 | $1.0M | Direct | Oct 30, 2025 (2d) |
| Oct 2, 2025 | ARQT | ↓ Sell | 45,000 | $19.66 | $885K | Direct | Oct 3, 2025 (1d) |
| Sep 9, 2025 | ARQT | ↓ Sell10b5-1 | 10,129 | $17.54 | $178K | Direct | Sep 10, 2025 (1d) |
| Aug 4, 2025 | ARQT | ↓ Sell | 11,547 | $14.33 | $165K | Direct | Aug 5, 2025 (1d) |
| May 2, 2025 | ARQT | ↓ Sell | 11,448 | $15.19 | $174K | Direct | May 5, 2025 (3d) |
| Mar 25, 2025 | ARQT | ↓ Sell10b5-1 | 3,671 | $17.55 | $64K | Direct | Mar 26, 2025 (1d) |
| Mar 17, 2025 | ARQT | ↓ Sell10b5-1 | 1,200 | $17.61 | $21K | Direct | Mar 20, 2025 (3d) |
| Mar 4, 2025 | ARQT | ↓ Sell | 25,015 | $13.07 | $327K | Direct | Mar 4, 2025 (0d) |
| Feb 3, 2025 | ARQT | ↓ Sell | 19,301 | $12.70 | $245K | Direct | Feb 4, 2025 (1d) |
| Dec 20, 2024 | ARQT | ↓ Sell10b5-1 | 15,000 | $15.17 | $228K | Direct | Dec 23, 2024 (3d) |
| Nov 30, 2024 | ARQT | ↑ Buy | 6,038 | $3.52 | $21K | Direct | Dec 3, 2024 (3d) |
| Nov 4, 2024 | ARQT | ↓ Sell | 13,871 | $8.68 | $120K | Direct | Nov 5, 2024 (1d) |
| Aug 2, 2024 | ARQT | ↓ Sell10b5-1 | 14,487 | $9.02 | $131K | Direct | Aug 5, 2024 (3d) |
| May 2, 2024 | ARQT | ↓ Sell10b5-1 | 13,783 | $8.74 | $120K | Direct | May 3, 2024 (1d) |
| Mar 4, 2024 | ARQT | ↓ Sell | 14,903 | $11.12 | $166K | Direct | Mar 6, 2024 (2d) |
| Feb 28, 2024 | ARQT | ↓ Sell | 2,465 | $10.60 | $26K | Direct | Mar 1, 2024 (2d) |
| May 31, 2023 | ARQT | ↑ Buy | 1,463 | $6.38 | $9K | Direct | Dec 1, 2023 (184d) |
| Mar 6, 2023 | ARQT | ↓ Sell | 2,435 | $15.26 | $37K | Direct | Mar 8, 2023 (2d) |
| Mar 2, 2023 | ARQT | ↓ Sell | 7,815 | $15.93 | $124K | Direct | Mar 2, 2023 (0d) |
| Feb 14, 2023 | ARQT | ↓ Sell | 1,000 | $17.01 | $17K | Direct | Feb 15, 2023 (1d) |
| Feb 1, 2023 | ARQT | ↓ Sell | 1,000 | $17.00 | $17K | Direct | Feb 3, 2023 (2d) |
| Dec 7, 2022 | ARQT | ↓ Sell | 1,000 | $17.06 | $17K | Direct | Dec 9, 2022 (2d) |
| Nov 7, 2022 | ARQT | ↓ Sell | 1,000 | $18.00 | $18K | Direct | Nov 9, 2022 (2d) |
| Oct 7, 2022 | ARQT | ↓ Sell | 1,000 | $19.51 | $20K | Direct | Oct 11, 2022 (4d) |
| Sep 7, 2022 | ARQT | ↓ Sell | 1,000 | $21.51 | $22K | Direct | Sep 9, 2022 (2d) |
| Aug 5, 2022 | ARQT | ↓ Sell | 2,500 | $24.74 | $62K | Direct | Aug 9, 2022 (4d) |
| Jul 8, 2022 | ARQT | ↓ Sell | 13,500 | $25.37 | $342K | Direct | Jul 12, 2022 (4d) |
| Jul 6, 2022 | ARQT | ↓ Sell | 1,000 | $22.07 | $22K | Direct | Jul 7, 2022 (1d) |
| Jun 6, 2022 | ARQT | ↓ Sell | 1,000 | $21.06 | $21K | Direct | Jun 6, 2022 (0d) |
| May 5, 2022 | ARQT | ↓ Sell | 1,000 | $21.76 | $22K | Direct | May 5, 2022 (0d) |
| Apr 5, 2022 | ARQT | ↓ Sell | 1,000 | $21.43 | $21K | Direct | Apr 5, 2022 (0d) |
| Mar 9, 2022 | ARQT | ↓ Sell10b5-1 | 300 | $17.00 | $5K | Direct | Mar 11, 2022 (2d) |
| Mar 7, 2022 | ARQT | ↓ Sell | 3,259 | $16.90 | $55K | Direct | Mar 7, 2022 (0d) |
| Mar 1, 2022 | ARQT | ↓ Sell | 2,153 | $17.75 | $38K | Direct | Mar 3, 2022 (2d) |
| Feb 9, 2022 | ARQT | ↓ Sell | 1,000 | $17.00 | $17K | Direct | Feb 11, 2022 (2d) |
| Jan 5, 2022 | ARQT | ↓ Sell | 1,000 | $21.59 | $22K | Direct | Jan 7, 2022 (2d) |
| Dec 8, 2021 | ARQT | ↓ Sell | 1,000 | $17.00 | $17K | Direct | Dec 10, 2021 (2d) |
| Nov 5, 2021 | ARQT | ↓ Sell | 1,000 | $21.50 | $22K | Direct | Nov 9, 2021 (4d) |
| Oct 5, 2021 | ARQT | ↓ Sell | 2,500 | $24.92 | $62K | Direct | Oct 7, 2021 (2d) |
| Oct 1, 2021 | ARQT | ↓ Sell | 1,500 | $25.01 | $38K | Direct | Oct 5, 2021 (4d) |
| Sep 7, 2021 | ARQT | ↓ Sell | 1,000 | $21.14 | $21K | Direct | Sep 9, 2021 (2d) |
| Aug 5, 2021 | ARQT | ↓ Sell | 1,000 | $20.81 | $21K | Direct | Aug 9, 2021 (4d) |
| Jul 6, 2021 | ARQT | ↓ Sell | 1,750 | $26.58 | $47K | Direct | Jul 8, 2021 (2d) |
| Jun 7, 2021 | ARQT | ↓ Sell | 1,750 | $26.35 | $46K | Direct | Jun 9, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ARQT insiders
Open-market trades in the last 12 months
About Todd Watanabe's insider trades
Todd Watanabe is See Remarks at Arcutis Biotherapeutics (ARQT). Since Sep 29, 2020, Todd has reported 2 open-market purchases worth $31K and 57 sales worth $8.5M on SEC Form 4. In the last 12 months: 5 sales ($2.4M).
7 sales (9% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (20 filings), grants and awards (6 filings), gifts (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARQT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.